In a satirical response, vancomycin defends its modern relevance by highlighting AUC-guided dosing, predictable pharmacokinetics, durability against resistance, and established clinical scenarios where it remains essential, while challenging assumptions about linezolid's convenience, toxicity profile, and emerging resistance concerns.
Haynes et al. (Wed,) studied this question.